| Year |
Citation |
Score |
| 2019 |
Breslow AS, Tran NM, Lu FQ, Alpert JE, Cook BL. Depression Treatment Expenditures for Adults in the USA: a Systematic Review. Current Psychiatry Reports. 21: 105. PMID 31541327 DOI: 10.1007/s11920-019-1083-3 |
0.398 |
|
| 2019 |
Nyer M, Hopkins LB, Farabaugh A, Nauphal M, Parkin S, McKee MM, Miller KK, Streeter C, Uebelacker LA, Fava M, Alpert JE, Pedrelli P, Mischoulon D. Community-Delivered Heated Hatha Yoga as a Treatment for Depressive Symptoms: An Uncontrolled Pilot Study. Journal of Alternative and Complementary Medicine (New York, N.Y.). PMID 31290694 DOI: 10.1089/Acm.2018.0365 |
0.565 |
|
| 2018 |
Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, ... ... Alpert JE, et al. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomedicine and Laser Surgery. PMID 30346890 DOI: 10.1089/Pho.2018.4490 |
0.645 |
|
| 2018 |
Ionescu DF, Bentley KH, Eikermann M, Taylor N, Johnson-Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, et al. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Journal of Affective Disorders. 243: 516-524. PMID 30286416 DOI: 10.1016/J.Jad.2018.09.037 |
0.613 |
|
| 2017 |
Yeung A, Wang F, Feng F, Zhang J, Cooper A, Hong L, Wang W, Griffiths K, Bennett K, Bennett A, Alpert J, Fava M. Outcomes of an online computerized cognitive behavioral treatment program for treating chinese patients with depression: A pilot study. Asian Journal of Psychiatry. PMID 29146042 DOI: 10.1016/J.Ajp.2017.11.007 |
0.56 |
|
| 2017 |
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. Journal of Affective Disorders. 227: 198. PMID 29100152 DOI: 10.1016/J.Jad.2017.10.040 |
0.612 |
|
| 2017 |
Yeung AS, Feng R, Kim DJH, Wayne PM, Yeh GY, Baer L, Lee OE, Denninger JW, Benson H, Fricchione GL, Alpert J, Fava M. A Pilot, Randomized Controlled Study of Tai Chi With Passive and Active Controls in the Treatment of Depressed Chinese Americans. The Journal of Clinical Psychiatry. 78: e522-e528. PMID 28570792 DOI: 10.4088/Jcp.16M10772 |
0.628 |
|
| 2017 |
de Jong M, Peeters F, Gard T, Ashih H, Doorley J, Walker R, Rhoades L, Kulich RJ, Kueppenbender KD, Alpert JE, Hoge EA, Britton WB, Lazar SW, Fava M, Mischoulon D. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain. The Journal of Clinical Psychiatry. PMID 28252881 DOI: 10.4088/Jcp.15M10160 |
0.532 |
|
| 2016 |
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of Affective Disorders. 208: 6-14. PMID 27736689 DOI: 10.1016/J.Jad.2016.08.029 |
0.636 |
|
| 2016 |
Ma Y, Yeung A, Yang AC, Peng CK, Clain A, Alpert J, Fava M, Yeung AS. The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study. Behavioral Sleep Medicine. 1-17. PMID 27676270 DOI: 10.1080/15402002.2016.1228643 |
0.578 |
|
| 2016 |
Chen JA, Shapero BG, Trinh NT, Chang TE, Parkin S, Alpert JE, Fava M, Yeung AS. Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care Setting. The Journal of Clinical Psychiatry. PMID 27631145 DOI: 10.4088/Jcp.15M10225 |
0.543 |
|
| 2016 |
Yeung A, Martinson MA, Baer L, Chen J, Clain A, Williams A, Chang TE, Trinh NT, Alpert JE, Fava M. The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: e996-e1002. PMID 27561153 DOI: 10.4088/Jcp.15M09952 |
0.564 |
|
| 2016 |
Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, et al. Inflammatory cytokines in major depressive disorder: A case-control study. The Australian and New Zealand Journal of Psychiatry. PMID 27313138 DOI: 10.1177/0004867416652736 |
0.601 |
|
| 2016 |
Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. The Journal of Clinical Psychiatry. PMID 27232360 DOI: 10.4088/Jcp.15M10056 |
0.533 |
|
| 2016 |
Huz I, Nyer M, Dickson C, Farabaugh A, Alpert J, Fava M, Baer L. Obsessive-Compulsive Symptoms as a Risk Factor for Suicidality in U.S. College Students. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 26803200 DOI: 10.1016/J.Jadohealth.2015.11.011 |
0.409 |
|
| 2015 |
Cassano P, Trinh NH, Chang T, Cusin C, Fisher L, Pedrelli P, Nyer M, Kim DJ, Alpert J, Mischoulon D. Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms. The Journal of Nervous and Mental Disease. PMID 26356091 DOI: 10.1097/Nmd.0000000000000365 |
0.42 |
|
| 2015 |
Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study. The Journal of Nervous and Mental Disease. 203: 762-8. PMID 26348584 DOI: 10.1097/Nmd.0000000000000364 |
0.624 |
|
| 2015 |
Ionescu DF, Rosenbaum JF, Alpert JE. Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues in Clinical Neuroscience. 17: 111-26. PMID 26246787 |
0.463 |
|
| 2015 |
Farabaugh A, Fisher L, Nyer M, Holt D, Cohen M, Baer L, Shapero BG, Huz I, Cardoos A, Fava M, Alpert JE. Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 118-26. PMID 25954938 |
0.454 |
|
| 2015 |
Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A. College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 100-8. PMID 25954936 |
0.537 |
|
| 2014 |
Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker RS, Fava M. Reliability and validity of the Symptoms of Depression Questionnaire (SDQ). Cns Spectrums. 19: 535-46. PMID 25275853 DOI: 10.1017/S1092852914000406 |
0.651 |
|
| 2013 |
Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D. Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. Journal of Clinical Psychopharmacology. 33: 827-30. PMID 24091858 DOI: 10.1097/Jcp.0B013E31829Cc3Af |
0.641 |
|
| 2013 |
Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ. Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. Journal of Psychiatric Research. 47: 706-11. PMID 23490066 DOI: 10.1016/J.Jpsychires.2013.02.005 |
0.441 |
|
| 2012 |
Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, ... Alpert JE, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. The American Journal of Psychiatry. 169: 1267-74. PMID 23212058 DOI: 10.1176/Appi.Ajp.2012.11071114 |
0.53 |
|
| 2012 |
Farabaugh A, Alpert J, Wisniewski SR, Otto MW, Fava M, Baer L, Perlis R, Friedman E, Nyer M, Bitran S, Balasubramani GK, Inamori A, Trivedi M, Thase ME. Cognitive therapy for anxious depression in STAR(*) D: what have we learned? Journal of Affective Disorders. 142: 213-8. PMID 22877961 DOI: 10.1016/J.Jad.2012.04.029 |
0.643 |
|
| 2012 |
Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. Cns Spectrums. 17: 76-86. PMID 22789065 DOI: 10.1017/S1092852912000430 |
0.467 |
|
| 2012 |
Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. The Journal of Clinical Psychiatry. 73: 843-8. PMID 22687580 DOI: 10.4088/Jcp.11M07139 |
0.544 |
|
| 2012 |
Soskin DP, Carl JR, Alpert J, Fava M. Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder. Cns Neuroscience & Therapeutics. 18: 441-51. PMID 22672296 DOI: 10.1111/J.1755-5949.2012.00318.X |
0.571 |
|
| 2012 |
Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. Journal of Affective Disorders. 136: 1174-8. PMID 21911258 DOI: 10.1016/J.Jad.2011.04.059 |
0.484 |
|
| 2012 |
Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 27: 518-21. PMID 21665441 DOI: 10.1016/J.Eurpsy.2011.03.006 |
0.484 |
|
| 2011 |
McClintock SM, Husain MM, Bernstein IH, Wisniewski SR, Trivedi MH, Morris D, Alpert J, Warden D, Luther JF, Kornstein SG, Biggs MM, Fava M, Rush AJ. Assessing anxious features in depressed outpatients. International Journal of Methods in Psychiatric Research. 20: e69-82. PMID 22057975 DOI: 10.1002/Mpr.353 |
0.593 |
|
| 2011 |
Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM. Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. The American Journal of Psychiatry. 168: 593-602. PMID 21406462 DOI: 10.1176/Appi.Ajp.2010.10010032 |
0.524 |
|
| 2011 |
Papakostas G, Shelton R, Zajecka J, Rickels K, Clain A, Baer L, Schoenfeld D, Nelson E, Barbee J, Lydiard B, Mischoulon D, Alpert J, Zisook S, Fava M. L-methylfolate augmentation of selective serotonin reuptake inhibitors (SSRIS) for major depressive disorder: Results of two randomized, double-blind trials European Psychiatry. 26: 592-592. DOI: 10.1016/S0924-9338(11)72299-4 |
0.482 |
|
| 2010 |
Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. The American Journal of Psychiatry. 167: 942-8. PMID 20595412 DOI: 10.1176/Appi.Ajp.2009.09081198 |
0.654 |
|
| 2010 |
Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. Journal of Clinical Psychopharmacology. 30: 193-7. PMID 20520295 DOI: 10.1097/Jcp.0B013E3181D20912 |
0.451 |
|
| 2010 |
Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, Baer L, Fava M, McGrath PJ, Dording C, Mischoulon D, Papakostas GI. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. International Clinical Psychopharmacology. 25: 214-7. PMID 20400905 DOI: 10.1097/Yic.0B013E328339Fbbd |
0.662 |
|
| 2010 |
Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-9. PMID 20332287 DOI: 10.1176/appi.psy.51.2.124 |
0.545 |
|
| 2010 |
Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-129. DOI: 10.1016/S0033-3182(10)70672-1 |
0.612 |
|
| 2009 |
Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskorn SH. Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report. Cns Spectrums. 14: 487-98. PMID 19890231 DOI: 10.1017/S1092852900023555 |
0.499 |
|
| 2009 |
Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M. Pattern of depressive symptoms in Parkinson's disease. Psychosomatics. 50: 448-54. PMID 19855029 DOI: 10.1176/appi.psy.50.5.448 |
0.603 |
|
| 2009 |
Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. The Journal of Clinical Psychiatry. 70: 1636-44. PMID 19709502 DOI: 10.4088/Jcp.08M04603 |
0.645 |
|
| 2009 |
Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology. 29: 372-7. PMID 19593178 DOI: 10.1097/Jcp.0B013E3181Ac4Aaf |
0.398 |
|
| 2009 |
Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 772-7. PMID 19574030 DOI: 10.1016/J.Euroneuro.2009.06.001 |
0.525 |
|
| 2009 |
Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. American Journal of Preventive Medicine. 36: 341-50. PMID 19285199 DOI: 10.1016/J.Amepre.2008.11.020 |
0.31 |
|
| 2009 |
Perlis RH, Fava M, Trivedi MH, Alpert J, Luther JF, Wisniewski SR, Rush AJ. Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatrica Scandinavica. 119: 282-9. PMID 19207123 DOI: 10.1111/J.1600-0447.2008.01298.X |
0.67 |
|
| 2008 |
Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, Fava M, et al. Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment. Journal of Youth and Adolescence. 37: 906-916. PMID 25013241 DOI: 10.1007/S10964-007-9216-0 |
0.579 |
|
| 2008 |
Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues in Clinical Neuroscience. 10: 409-18. PMID 19170398 |
0.343 |
|
| 2008 |
Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology. 28: 660-6. PMID 19011435 DOI: 10.1097/Jcp.0B013E31818Ad7D6 |
0.59 |
|
| 2008 |
Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, et al. Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 37: 714-24. PMID 18991123 DOI: 10.1080/15374410802359726 |
0.622 |
|
| 2008 |
Lesser I, Rosales A, Zisook S, Gonzalez C, Flores D, Trivedi M, Sciolla A, Luther J, Wisniewski S, Alpert J, Cook I, Rush AJ, Epstein M. Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. Psychiatric Services (Washington, D.C.). 59: 1273-84. PMID 18971403 DOI: 10.1176/Appi.Ps.59.11.1273 |
0.453 |
|
| 2008 |
Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. The Journal of Clinical Psychiatry. 69: 1246-56. PMID 18681756 DOI: 10.4088/Jcp.V69N0807 |
0.656 |
|
| 2008 |
Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biological Psychiatry. 64: 455-60. PMID 18571625 DOI: 10.1016/J.Biopsych.2008.04.036 |
0.441 |
|
| 2008 |
Pilowsky DJ, Wickramaratne P, Talati A, Tang M, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, et al. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. The American Journal of Psychiatry. 165: 1136-47. PMID 18558646 DOI: 10.1176/Appi.Ajp.2008.07081286 |
0.626 |
|
| 2008 |
Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 639-45. PMID 18539007 DOI: 10.1016/J.Euroneuro.2008.04.011 |
0.528 |
|
| 2008 |
Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatrica Scandinavica. 117: 271-6. PMID 18307587 DOI: 10.1111/J.1600-0447.2008.01156.X |
0.578 |
|
| 2008 |
Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. The American Journal of Psychiatry. 165: 342-51. PMID 18172020 DOI: 10.1176/Appi.Ajp.2007.06111868 |
0.653 |
|
| 2008 |
Nierenberg AA, Alpert JE, Gaynes BN, Warden D, Wisniewski SR, Biggs MM, Trivedi MH, Barkin JL, Rush AJ. Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. Journal of Affective Disorders. 108: 129-34. PMID 18006073 DOI: 10.1016/J.Jad.2007.10.011 |
0.443 |
|
| 2008 |
Mooney JJ, Samson JA, Hennen J, Pappalardo K, McHale N, Alpert J, Koutsos M, Schildkraut JJ. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). Journal of Psychiatric Research. 42: 605-11. PMID 17727882 DOI: 10.1016/J.Jpsychires.2007.07.009 |
0.363 |
|
| 2008 |
Papakostas GI, Trivedi MH, Alpert JE, Seifert CA, Krishen A, Goodale EP, Tucker VL. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. Journal of Psychiatric Research. 42: 134-40. PMID 17631898 DOI: 10.1016/J.Jpsychires.2007.05.012 |
0.542 |
|
| 2008 |
Farabaugh A, Mischoulon D, Schwartz F, Pender M, Fava M, Alpert J. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD. Depression and Anxiety. 24: 433-9. PMID 17086540 DOI: 10.1002/Da.20174 |
0.543 |
|
| 2008 |
Nierenberg AA, Alpert JE, Gaynes BN, Warden D, Wisniewski SR, Biggs MM, Trivedi MH, Barkin JL, Rush AJ. Family history of completed suicide and characteristics of major depressive disorder: A STAR*D (sequenced treatment alternatives to relieve depression) study | Antecedentes familiares de suicidio consumado y características del trastorno depresivo mayor: Estudio STAR*D (sequenced treatment alternatives to relieve depression) Psiquiatria Biologica. 15: 195-201. |
0.453 |
|
| 2007 |
Papakostas GI, Hallett LA, Smith J, Tossani E, Mascarini A, Burns AM, Birnbaum RJ, Fava M, Alpert JE. A survey of five antidepressant properties influencing clinician's treatment choices in MDD. Neuropsychiatric Disease and Treatment. 3: 169-72. PMID 19300547 DOI: 10.2147/Nedt.2007.3.1.169 |
0.633 |
|
| 2007 |
Davis LL, Frazier EC, Gaynes BN, Trivedi MH, Wisniewski SR, Fava M, Barkin J, Kashner TM, Shelton RC, Alpert JE, Rush AJ. Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. The Journal of Clinical Psychiatry. 68: 1931-8. PMID 18162025 DOI: 10.4088/Jcp.V68N1214 |
0.578 |
|
| 2007 |
Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR. Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Medical Care. 45: 1043-51. PMID 18049344 DOI: 10.1097/Mlr.0B013E3181271462 |
0.52 |
|
| 2007 |
Talati A, Wickramaratne PJ, Pilowsky DJ, Alpert JE, Cerda G, Garber J, Hughes CW, King CA, Malloy E, Sood AB, Verdeli H, Trivedi MH, Rush AJ, Weissman MM. Remission of maternal depression and child symptoms among single mothers: a STAR*D-Child report. Social Psychiatry and Psychiatric Epidemiology. 42: 962-71. PMID 17934684 DOI: 10.1007/S00127-007-0262-4 |
0.492 |
|
| 2007 |
Fraguas R, Iosifescu DV, Alpert J, Wisniewski SR, Barkin JL, Trivedi MH, Rush AJ, Fava M. Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. Psychosomatics. 48: 418-25. PMID 17878501 DOI: 10.1176/Appi.Psy.48.5.418 |
0.643 |
|
| 2007 |
Fraguas R, Iosifescu DV, Bankier B, Perlis R, Clementi-Craven N, Alpert J, Fava M. Major depressive disorder with anger attacks and cardiovascular risk factors. International Journal of Psychiatry in Medicine. 37: 99-111. PMID 17645202 DOI: 10.2190/Y361-2W83-268H-5W7V |
0.596 |
|
| 2007 |
Petersen T, Fava M, Alpert JE, Vorono S, Sanders KM, Mischoulon D. Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 31: 281-9. PMID 17626190 DOI: 10.1176/Appi.Ap.31.4.281 |
0.351 |
|
| 2007 |
Papakostas GI, Petersen T, Homberger CH, Green CH, Smith J, Alpert JE, Fava M. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 5-8. PMID 17453655 DOI: 10.1080/10401230601163451 |
0.657 |
|
| 2007 |
Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, Balasubramani GK, Alpert JE, Fava M. Preadult onset vs. adult onset of major depressive disorder: a replication study. Acta Psychiatrica Scandinavica. 115: 196-205. PMID 17302619 DOI: 10.1111/J.1600-0447.2006.00868.X |
0.659 |
|
| 2007 |
Papakostas GI, Petersen T, Sklarsky KG, Nierenberg AA, Alpert JE, Fava M. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Research. 149: 195-200. PMID 17157390 DOI: 10.1016/J.Psychres.2006.03.014 |
0.612 |
|
| 2007 |
Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. Journal of Affective Disorders. 97: 77-84. PMID 16824617 DOI: 10.1016/J.Jad.2006.05.026 |
0.516 |
|
| 2007 |
Sonawalla S, Farabaugh A, Yeung A, Mischoulon D, Alpert J, Fava M. P.2.a.032 Sleep disturbance and suicidal ideation among college students European Neuropsychopharmacology. 17: S330. DOI: 10.1016/S0924-977X(07)70474-1 |
0.362 |
|
| 2007 |
Talati A, Wickramaratne PJ, Pilowsky DJ, Alpert JE, Cerda G, Garber J, Hughes CW, King CA, Malloy E, Sood AB, Verdeli H, Trivedi MH, Rush AJ, Weissman MM. Remission of maternal depression and child symptoms among single mothers Social Psychiatry and Psychiatric Epidemiology. 42: 971-971. DOI: 10.1007/S00127-007-0298-5 |
0.463 |
|
| 2006 |
Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, Papakostas GI. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry. 67: 1754-9. PMID 17196056 DOI: 10.4088/Jcp.V67N1113 |
0.499 |
|
| 2006 |
Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 51: 823-35. PMID 17195602 DOI: 10.1177/070674370605101304 |
0.668 |
|
| 2006 |
McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E. Predictors of relapse in a prospective study of fluoxetine treatment of major depression. The American Journal of Psychiatry. 163: 1542-8. PMID 16946178 DOI: 10.1176/Appi.Ajp.163.9.1542 |
0.568 |
|
| 2006 |
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. The American Journal of Psychiatry. 163: 1519-30; quiz 1665. PMID 16946176 DOI: 10.1176/Ajp.2006.163.9.1519 |
0.651 |
|
| 2006 |
Denninger JW, Papakostas GI, Mahal Y, Merens W, Alpert JE, Nierenberg AA, Yeung A, Fava M. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine. Psychosomatics. 47: 348-52. PMID 16844895 DOI: 10.1176/Appi.Psy.47.4.348 |
0.619 |
|
| 2006 |
Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. The American Journal of Psychiatry. 163: 1161-72. PMID 16816220 DOI: 10.1176/Appi.Ajp.163.7.1161 |
0.603 |
|
| 2006 |
Alpert JE. Improving depression outcome: new concepts, strategies and technologies. Journal of Psychopharmacology (Oxford, England). 20: 3-4. PMID 16644765 DOI: 10.1177/1359786806064304 |
0.43 |
|
| 2006 |
Papakostas GI, Petersen TJ, Perlis RH, Judy AE, Burns AM, Alpert JE, Birnbaum RJ, Fava M. A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder. Journal of Clinical Psychopharmacology. 26: 216-8. PMID 16633159 DOI: 10.1097/01.Jcp.0000203226.79364.5E |
0.6 |
|
| 2006 |
Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. Jama. 295: 1389-98. PMID 16551710 DOI: 10.1001/Jama.295.12.1389 |
0.615 |
|
| 2006 |
Alpert JE, Biggs MM, Davis L, Shores-Wilson K, Harlan WR, Schneider GW, Ford AL, Farabaugh A, Stegman D, Ritz AL, Husain MM, Macleod L, Wisniewski SR, Rush AJ. Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Psychiatry Research. 141: 193-200. PMID 16457894 DOI: 10.1016/J.Psychres.2005.04.007 |
0.438 |
|
| 2006 |
Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Wisniewski SR, Trivedi MH, Talati A, Carlson MM, Liu HH, et al. Children of currently depressed mothers: a STAR*D ancillary study. The Journal of Clinical Psychiatry. 67: 126-36. PMID 16426099 DOI: 10.4088/Jcp.V67N0119 |
0.644 |
|
| 2006 |
Fraguas R, Papakostas GI, Mischoulon D, Bottiglieri T, Alpert JE, Fava M. Anger attacks in major depressive disorder and serum levels of homocysteine. Biological Psychiatry. 60: 270-274. PMID 16325154 DOI: 10.1016/J.Biopsych.2005.08.026 |
0.639 |
|
| 2006 |
Alpert J, Detke M, Lecrubier Y, Schläpfer T. C.12.01 Current controversies in depression treatment: a hot topics panel European Neuropsychopharmacology. 16: S581. DOI: 10.1016/S0924-977X(06)70842-2 |
0.409 |
|
| 2006 |
Weissman MM, Alpert JE, Fava M, Trivedi MH, Rush AJ. Remission of Maternal Depression and Children’s Psychopathology—Reply Jama. 296: 1229. DOI: 10.1001/Jama.296.10.1233-B |
0.623 |
|
| 2005 |
Yeung A, Kung WW, Murakami JL, Mischoulon D, Alpert JE, Nierenberg AA, Fava M. Outcomes of recognizing depressed Chinese American patients in primary care. International Journal of Psychiatry in Medicine. 35: 213-24. PMID 16480237 DOI: 10.2190/11Da-Xnqr-Wyxr-Agxk |
0.627 |
|
| 2005 |
Iosifescu DV, Papakostas GI, Lyoo IK, Lee HK, Renshaw PF, Alpert JE, Nierenberg A, Fava M. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Research. 140: 291-9. PMID 16298109 DOI: 10.1016/j.pscychresns.2005.09.003 |
0.425 |
|
| 2005 |
Papakostas GI, Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Alpert JE, Nierenberg AA, Fava M. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II). Psychiatry Research. 140: 301-7. PMID 16297603 DOI: 10.1016/J.Pscychresns.2005.09.001 |
0.541 |
|
| 2005 |
Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica. 112: 425-33. PMID 16279871 DOI: 10.1111/J.1600-0447.2005.00633.X |
0.493 |
|
| 2005 |
Farabaugh A, Ongur D, Fava M, Hamill SK, Burns AM, Alpert J. Personality disorders and the trimensional personality questionnaire factors in major depressive disorder. The Journal of Nervous and Mental Disease. 193: 747-50. PMID 16260931 DOI: 10.1097/01.Nmd.0000185873.36662.76 |
0.583 |
|
| 2005 |
Papakostas GI, Petersen TJ, Kinrys G, Burns AM, Worthington JJ, Alpert JE, Fava M, Nierenberg AA. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 66: 1326-30. PMID 16259548 DOI: 10.4088/Jcp.V66N1017 |
0.63 |
|
| 2005 |
Iosifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE, Nierenberg AA, Fava M. Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosomatic Medicine. 67: 703-6. PMID 16204427 DOI: 10.1097/01.Psy.0000170338.75346.D0 |
0.644 |
|
| 2005 |
Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Comprehensive Psychiatry. 46: 266-71. PMID 16175757 DOI: 10.1016/J.Comppsych.2004.10.005 |
0.604 |
|
| 2005 |
Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. Journal of Clinical Psychopharmacology. 25: 441-7. PMID 16160619 DOI: 10.1097/01.Jcp.0000178416.60426.29 |
0.566 |
|
| 2005 |
Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 66: 1038-42. PMID 16086620 DOI: 10.4088/Jcp.V66N0812 |
0.615 |
|
| 2005 |
Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 523-8. PMID 15877935 DOI: 10.1017/S1461145705005195 |
0.593 |
|
| 2005 |
Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients. International Clinical Psychopharmacology. 20: 87-91. PMID 15729083 DOI: 10.1097/00004850-200503000-00004 |
0.596 |
|
| 2005 |
Farabaugh A, Mischoulon D, Fava M, Guyker W, Alpert J. The overlap between personality disorders and major depressive disorder (MDD). Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 16: 217-24. PMID 15702570 DOI: 10.1080/10401230490522043 |
0.613 |
|
| 2005 |
Farabaugh AH, Mischoulon D, Fava M, Green C, Guyker W, Alpert J. The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD). Acta Psychiatrica Scandinavica. 110: 465-70. PMID 15521832 DOI: 10.1111/J.1600-0447.2004.00377.X |
0.645 |
|
| 2005 |
Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, Rosenbaum JF, Fava M. Obesity among outpatients with major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 59-63. PMID 15361263 DOI: 10.1017/S1461145704004602 |
0.463 |
|
| 2005 |
Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. Erratum: The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine (International Journal of Neuropsychopharmacology (2005) DOI: 10.1017/S1461145705005195) The International Journal of Neuropsychopharmacology. 8. DOI: 10.1017/S1461145705005742 |
0.564 |
|
| 2004 |
Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine. 34: 1299-308. PMID 15697056 DOI: 10.1017/S0033291704002612 |
0.672 |
|
| 2004 |
Zisook S, John Rush A, Albala A, Alpert J, Balasubramani GK, Fava M, Husain M, Sackeim H, Trivedi M, Wisniewski S. Factors that differentiate early vs. later onset of major depression disorder Psychiatry Research. 129: 127-140. PMID 15590040 DOI: 10.1016/J.Psychres.2004.07.004 |
0.615 |
|
| 2004 |
Alpert JE, Papakostas G, Mischoulon D, Worthington JJ, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. Journal of Clinical Psychopharmacology. 24: 661-4. PMID 15538131 DOI: 10.1097/01.Jcp.0000145339.45794.Cd |
0.525 |
|
| 2004 |
Murck H, Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Mannel M, Rosenbaum JF. Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo. The International Journal of Neuropsychopharmacology. 8: 215-21. PMID 15458612 DOI: 10.1017/S1461145704004717 |
0.565 |
|
| 2004 |
Papakostas GI, Petersen T, Denninger JW, Tossani E, Pava JA, Alpert JE, Nierenberg AA, Fava M. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. Journal of Clinical Psychopharmacology. 24: 507-11. PMID 15349006 DOI: 10.1097/01.Jcp.0000138761.85363.D5 |
0.6 |
|
| 2004 |
Iosifescu DV, Nierenberg AA, Alpert JE, Papakostas GI, Perlis RH, Sonawalla S, Fava M. Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. 45: 419-25. PMID 15345787 DOI: 10.1176/Appi.Psy.45.5.419 |
0.653 |
|
| 2004 |
Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. The Journal of Clinical Psychiatry. 65: 1096-8. PMID 15323595 DOI: 10.4088/Jcp.V65N0811 |
0.591 |
|
| 2004 |
Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. The Journal of Clinical Psychiatry. 65: 1090-5. PMID 15323594 DOI: 10.4088/Jcp.V65N0810 |
0.636 |
|
| 2004 |
Alpert JE, Franznick DA, Hollander SB, Fava M. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. The Journal of Clinical Psychiatry. 65: 1069-75. PMID 15323591 DOI: 10.4088/Jcp.V65N0807 |
0.666 |
|
| 2004 |
Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychological Medicine. 34: 555-61. PMID 15259840 DOI: 10.1017/S0033291703001028 |
0.572 |
|
| 2004 |
Papakostas GI, Iosifescu DV, Petersen T, Hamill SK, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. Journal of Clinical Psychopharmacology. 24: 467-9. PMID 15232350 DOI: 10.1097/01.Jcp.0000132343.58584.1D |
0.599 |
|
| 2004 |
Petersen T, Papakostas GI, Mahal Y, Guyker WM, Beaumont EC, Alpert JE, Fava M, Nierenberg AA. Psychosocial functioning in patients with treatment resistant depression. European Psychiatry : the Journal of the Association of European Psychiatrists. 19: 196-201. PMID 15196600 DOI: 10.1016/J.Eurpsy.2003.11.006 |
0.643 |
|
| 2004 |
Papakostas GI, Petersen T, Hughes ME, Nierenberg AA, Alpert JE, Fava M. Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. Psychiatry Research. 126: 287-90. PMID 15157754 DOI: 10.1016/J.Psychres.2004.02.007 |
0.626 |
|
| 2004 |
Perlis RH, Iosifescu DV, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M. Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression. Psychosomatics. 45: 224-9. PMID 15123848 DOI: 10.1176/Appi.Psy.45.3.224 |
0.673 |
|
| 2004 |
Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky KG, Alpert JE, Nierenberg AA, Fava M. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. The Journal of Clinical Psychiatry. 65: 543-6. PMID 15119918 DOI: 10.4088/Jcp.V65N0414 |
0.642 |
|
| 2004 |
Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Controlled Clinical Trials. 25: 119-42. PMID 15061154 DOI: 10.1016/S0197-2456(03)00112-0 |
0.603 |
|
| 2004 |
Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. The Journal of Clinical Psychiatry. 65: 217-21. PMID 15003076 DOI: 10.4088/Jcp.V65N0212 |
0.617 |
|
| 2004 |
Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF, Fava M. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day. Acta Psychiatrica Scandinavica. 108: 432-8. PMID 14616224 DOI: 10.1046/J.0001-690X.2003.00168.X |
0.592 |
|
| 2004 |
Baldessarini RJ, Nordby G, Ekeberg Ø, Knardahl S, Os I, Bleeker JK, Lamers LM, Leenders IM, Kruyssen DC, Simoons ML, Trijsburg RW, Erdman RA, Fukunishi I, Moroji T, Okabe S, ... ... Alpert JE, et al. Subject Index Vol. 63, 1995 Psychotherapy and Psychosomatics. 63: 216-216. DOI: 10.1159/000288966 |
0.349 |
|
| 2004 |
Nierenberg AA, Fava M, Alpert J, Lagomasimo I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rossenbaum JF. Reply to Comments by Drs. Bschor and Bauer Journal of Clinical Psychopharmacology. 24: 241-242. DOI: 10.1097/01.Jcp.0000124342.57290.37 |
0.343 |
|
| 2004 |
Sonawalla S, Beaumont E, Mahal Y, Iosifescu D, Mischoulon D, Alpert J, Fava M. P.1.128 Depressive symptoms and suicidal ideationamong college students: A study of 752 students in the Boston area European Neuropsychopharmacology. 14: S230-S231. DOI: 10.1016/S0924-977X(04)80216-5 |
0.497 |
|
| 2003 |
Papakostas GI, Petersen T, Denninger JW, Montoya HD, Nierenberg AA, Alpert JE, Fava M. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 15: 187-92. PMID 14971864 DOI: 10.1023/B:Acli.0000008172.20590.22 |
0.559 |
|
| 2003 |
Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. The Journal of Clinical Psychiatry. 64: 13-7. PMID 14658986 |
0.478 |
|
| 2003 |
Papakostas GI, Petersen TJ, Farabaugh AH, Murakami JL, Pava JA, Alpert JE, Fava M, Nierenberg AA. Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 64: 1357-61. PMID 14658951 DOI: 10.4088/Jcp.V64N1112 |
0.644 |
|
| 2003 |
Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M. The impact of medical comorbidity on acute treatment in major depressive disorder. The American Journal of Psychiatry. 160: 2122-7. PMID 14638581 DOI: 10.1176/Appi.Ajp.160.12.2122 |
0.625 |
|
| 2003 |
Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Current Psychiatry Reports. 5: 460-6. PMID 14609501 DOI: 10.1007/S11920-003-0085-2 |
0.63 |
|
| 2003 |
Petersen TJ, Alpert JE, Papakostas GI, Bernstein EM, Freed R, Smith MM, Fava M. Early-onset depression and the emotional and behavioral characteristics of offspring. Depression and Anxiety. 18: 104-8. PMID 12964178 DOI: 10.1002/Da.10118 |
0.561 |
|
| 2003 |
Papakostas GI, Petersen T, Worthington JJ, Roffi PA, Alpert JE, Fava M, Nierenberg AA. A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed. International Clinical Psychopharmacology. 18: 293-6. PMID 12920390 DOI: 10.1097/00004850-200309000-00006 |
0.597 |
|
| 2003 |
Papakostas GI, Petersen T, Pava J, Masson E, Worthington JJ, Alpert JE, Fava M, Nierenberg AA. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome. The Journal of Nervous and Mental Disease. 191: 444-9. PMID 12891091 DOI: 10.1097/01.Nmd.0000081591.46444.97 |
0.611 |
|
| 2003 |
Papakostas GI, Petersen T, Iosifescu DV, Roffi PA, Alpert JE, Rosenbaum JF, Fava M, Nierenberg AA. Axis III disorders in treatment-resistant major depressive disorder. Psychiatry Research. 118: 183-8. PMID 12798983 DOI: 10.1016/S0165-1781(03)00067-2 |
0.606 |
|
| 2003 |
Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Research. 118: 137-45. PMID 12798978 DOI: 10.1016/S0165-1781(03)00066-0 |
0.483 |
|
| 2003 |
Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M, Nierenberg AA. Serum cholesterol in treatment-resistant depression. Neuropsychobiology. 47: 146-51. PMID 12759558 DOI: 10.1159/000070584 |
0.621 |
|
| 2003 |
Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE, Nierenberg AA, Fava M. Somatic symptoms in treatment-resistant depression. Psychiatry Research. 118: 39-45. PMID 12759160 DOI: 10.1016/S0165-1781(03)00063-5 |
0.535 |
|
| 2003 |
Alpert JE, Petersen T, Roffi PA, Papakostas GI, Freed R, Smith MM, Spector AR, Nierenberg AA, Rosenbaum JF, Fava M. Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks. Psychotherapy and Psychosomatics. 72: 102-6. PMID 12601228 DOI: 10.1159/000068682 |
0.519 |
|
| 2003 |
Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M. Nortriptyline for treatment-resistant depression. The Journal of Clinical Psychiatry. 64: 35-9. PMID 12590621 DOI: 10.4088/Jcp.V64N0108 |
0.638 |
|
| 2003 |
Nierenberg AA, Papakostas GI, Petersen T, Montoya HD, Worthington JJ, Tedlow J, Alpert JE, Fava M. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. Journal of Clinical Psychopharmacology. 23: 92-5. PMID 12544380 DOI: 10.1097/00004714-200302000-00013 |
0.634 |
|
| 2003 |
Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA. Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. Comprehensive Psychiatry. 44: 44-50. PMID 12524635 DOI: 10.1053/Comp.2003.50012 |
0.544 |
|
| 2002 |
Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology. 22: 474-80. PMID 12352270 DOI: 10.1097/00004714-200210000-00006 |
0.654 |
|
| 2002 |
Tedlow J, Smith M, Neault N, Polania L, Alpert J, Nierenberg A, Fava M. Melancholia and axis II comorbidity. Comprehensive Psychiatry. 43: 331-5. PMID 12216007 DOI: 10.1053/Comp.2002.34631 |
0.642 |
|
| 2002 |
Fava M, Farabaugh AH, Sickinger AH, Wright E, Alpert JE, Sonawalla S, Nierenberg AA, Worthington JJ. Personality disorders and depression. Psychological Medicine. 32: 1049-57. PMID 12214786 DOI: 10.1017/S0033291702005780 |
0.602 |
|
| 2002 |
Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Journal of Clinical Psychopharmacology. 22: 379-87. PMID 12172337 DOI: 10.1097/00004714-200208000-00008 |
0.526 |
|
| 2002 |
Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M. Body dysmorphic disorder in outpatients with major depression. Journal of Affective Disorders. 69: 141-8. PMID 12103460 DOI: 10.1016/S0165-0327(01)00304-4 |
0.646 |
|
| 2002 |
Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 14: 33-8. PMID 12046638 DOI: 10.1023/A:1015271927517 |
0.653 |
|
| 2002 |
Farabaugh A, Mischoulon D, Yeung A, Alpert J, Matthews J, Pava J, Fava M. Predictors of stable personality disorder diagnoses in outpatients with remitted depression Journal of Nervous and Mental Disease. 190: 248-256. PMID 11960086 DOI: 10.1097/00005053-200204000-00006 |
0.577 |
|
| 2002 |
Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. A survey of prescribing practices in the treatment of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 177-87. PMID 11853110 DOI: 10.1016/S0278-5846(01)00250-0 |
0.504 |
|
| 2002 |
Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Research. 109: 9-16. PMID 11850046 DOI: 10.1016/S0165-1781(01)00359-6 |
0.625 |
|
| 2001 |
Iosifescu DV, Howarth S, Alpert JE, Nierenberg AA, Worthington JJ, Fava M. T3 blood levels and treatment outcome in depression. International Journal of Psychiatry in Medicine. 31: 367-73. PMID 11949735 DOI: 10.2190/6Fk8-Dbgl-Mwr1-Mv58 |
0.623 |
|
| 2001 |
Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenberg A, Quitkin FM, Sackeim HA, Thase ME, Trivedi M. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biological Psychiatry. 50: 792-801. PMID 11720698 DOI: 10.1016/S0006-3223(01)01223-9 |
0.474 |
|
| 2001 |
Petersen T, Bottonari K, Alpert JE, Fava M, Nierenberg AA. Use of the five-factory inventory in characterizing patients with major depressive disorder Comprehensive Psychiatry. 42: 488-493. PMID 11704941 DOI: 10.1053/Comp.2001.27897 |
0.646 |
|
| 2001 |
Spillmann MK, Van der Does AJW, Rankin MA, Vuolo RD, Alpert JE, Nierenberg AA, Rosenbaum JF, Hayden D, Schoenfeld D, Fava M. Tryptophan depletion in SSRI-recovered depressed outpatients Psychopharmacology. 155: 123-127. PMID 11400999 DOI: 10.1007/S002130000669 |
0.648 |
|
| 2001 |
Mischoulon D, McColl-Vuolo R, Howarth S, Lagomasino IT, Alpert JE, Nierenberg AA, Fava M. Management of major depression in the primary care setting Psychotherapy and Psychosomatics. 70: 103-107. PMID 11244391 DOI: 10.1159/000056233 |
0.561 |
|
| 2000 |
Nierenberg AA, Alpert JE. Depressive breakthrough Psychiatric Clinics of North America. 23: 731-742. PMID 11147244 DOI: 10.1016/S0193-953X(05)70194-5 |
0.434 |
|
| 2000 |
Mischoulon D, Burger JK, Spillmann MK, Worthington JJ, Fava M, Alpert JE. Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression. Journal of Psychosomatic Research. 49: 183-7. PMID 11110989 DOI: 10.1016/S0022-3999(00)00158-6 |
0.578 |
|
| 2000 |
Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, Worthington JJ, Rosenbaum JF, Fava M. Timing of onset of antidepressant response with fluoxetine treatment. The American Journal of Psychiatry. 157: 1423-8. PMID 10964858 DOI: 10.1176/Appi.Ajp.157.9.1423 |
0.488 |
|
| 2000 |
Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: Focus on folate Nutrition. 16: 544-546. PMID 10906550 DOI: 10.1016/S0899-9007(00)00327-0 |
0.631 |
|
| 2000 |
Fava M, Vuolo RD, Wright EC, Nierenberg AA, Alpert JE, Rosenbaum JF. Fenfluramine challenge in unipolar depression with and without anger attacks. Psychiatry Research. 94: 9-18. PMID 10788673 DOI: 10.1016/S0165-1781(00)00120-7 |
0.65 |
|
| 2000 |
Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF. Anxiety disorders in major depression. Comprehensive Psychiatry. 41: 97-102. PMID 10741886 DOI: 10.1016/S0010-440X(00)90140-8 |
0.655 |
|
| 2000 |
Sonawalla S, Hutchins A, Delgado M, Johnson M, Worthington J, Alpert J, Fava M. Onset of response to fluoxetine treatment as assessed by the symptom questionnaire European Neuropsychopharmacology. 10: 278. DOI: 10.1016/S0924-977X(00)80276-X |
0.462 |
|
| 1999 |
Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders Journal of Clinical Psychiatry. 60: 580-583. PMID 10520975 DOI: 10.4088/Jcp.V60N0903 |
0.669 |
|
| 1999 |
Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. The American Journal of Psychiatry. 156: 1638-40. PMID 10518178 DOI: 10.1176/Ajp.156.10.1638 |
0.484 |
|
| 1999 |
Fava M, Rosenbaum JF, Kolsky AR, Alpert JE, Nierenberg AA, Spillmann M, Moore C, Renshaw P, Bottiglieri T, Moroz G, Magni G. Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder Journal of Clinical Psychopharmacology. 19: 329-335. PMID 10440460 DOI: 10.1097/00004714-199908000-00008 |
0.618 |
|
| 1999 |
Alpert JE, Fava M, Uebelacker LA, Nierenberg AA, Pava JA, Worthington JJ, Rosenbaum JF. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biological Psychiatry. 46: 202-11. PMID 10418695 DOI: 10.1016/S0006-3223(99)00017-7 |
0.627 |
|
| 1999 |
Tedlow J, Leslie V, Keefe BR, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M. Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks. Journal of Affective Disorders. 52: 217-23. PMID 10357036 DOI: 10.1016/S0165-0327(98)00074-3 |
0.612 |
|
| 1999 |
Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M. Residual symptoms in depressed patients who respond acutely to fluoxetine. The Journal of Clinical Psychiatry. 60: 221-5. PMID 10221281 DOI: 10.4088/Jcp.V60N0403 |
0.551 |
|
| 1999 |
Sonawalla S, Farabaugh A, Leslie V, Alpert J, Nierenberg A, Fava M. True drug response versus placebo pattern response to fluoxetine: Differences in cognitive factors European Neuropsychopharmacology. 9: 234. DOI: 10.1016/S0924-977X(99)80187-4 |
0.387 |
|
| 1999 |
Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M. Residual symptoms in depressed patients who respond acutely to fluoxetine Primary Care Companion to the Journal of Clinical Psychiatry. 1: 124. |
0.407 |
|
| 1998 |
Nierenberg AA, Alpert JE, Pava J, Rosenbaum JF, Fava M. Course and treatment of atypical depression Journal of Clinical Psychiatry. 59: 5-9. PMID 9840192 |
0.506 |
|
| 1998 |
Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ. An open trial of oral sildenafilin antidepressant-induced sexual dysfunction. Psychotherapy and Psychosomatics. 67: 328-31. PMID 9817955 DOI: 10.1159/000012299 |
0.408 |
|
| 1998 |
Tedlow J, Fava M, Uebelacker L, Nierenberg AA, Alpert JE, Rosenbaum J. Outcome definitions and predictors in depression Psychotherapy and Psychosomatics. 67: 266-270. PMID 9693355 DOI: 10.1159/000012290 |
0.643 |
|
| 1998 |
Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biological Psychiatry. 43: 574-83. PMID 9564442 DOI: 10.1016/S0006-3223(97)00327-2 |
0.348 |
|
| 1998 |
Melin L, Viemerö V, Krause C, Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ, Hägnebo C, Andersson G, Fava GA, Montanari A, Lökk J, Hillert L, Hedman BK, et al. Contents, Vol. 67, 1998 Psychotherapy and Psychosomatics. 67. DOI: 10.1159/000345691 |
0.344 |
|
| 1998 |
Sonawalla S, Pingol M, Delgado M, Alpert J, Nierenberg A, Rosenbaum[auM. Fava J, Fava M. Fluoxetine treatment of patients with anxious depression European Neuropsychopharmacology. 8: S141. DOI: 10.1016/S0924-977X(98)80143-0 |
0.649 |
|
| 1997 |
Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. The American Journal of Psychiatry. 154: 1760-2. PMID 9396960 DOI: 10.1176/Ajp.154.12.1760 |
0.406 |
|
| 1997 |
Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF. Major depressive subtypes and treatment response Biological Psychiatry. 42: 568-576. PMID 9376453 DOI: 10.1016/S0006-3223(96)00440-4 |
0.689 |
|
| 1997 |
Alpert JE, Fava M. Nutrition and depression: The role of folate Nutrition Reviews. 55: 145-149. PMID 9212690 DOI: 10.1111/J.1753-4887.1997.Tb06468.X |
0.584 |
|
| 1997 |
Alpert JE, Spillmann MK. Psychotherapeutic approaches to aggressive and violent patients Psychiatric Clinics of North America. 20: 453-472. PMID 9196924 DOI: 10.1016/S0193-953X(05)70322-1 |
0.346 |
|
| 1997 |
Alpert JE, Uebelacker LA, McLean NE, Nierenberg AA, Pava JA, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M. Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychological Medicine. 27: 627-33. PMID 9153683 DOI: 10.1017/S0033291797004765 |
0.623 |
|
| 1997 |
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder American Journal of Psychiatry. 154: 426-428. PMID 9054796 DOI: 10.1176/Ajp.154.3.426 |
0.635 |
|
| 1996 |
Fava M, Davidson K, Alpert JE, Nierenberg AA, Worthington J, O'Sullivan R, Rosenbaum JF. Hostility changes following antidepressant treatment: Relationship to stress and negative thinking Journal of Psychiatric Research. 30: 459-467. PMID 9023789 DOI: 10.1016/S0022-3956(96)00034-9 |
0.617 |
|
| 1996 |
Worthington J, Fava M, Agustin C, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF. Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 37: 518-22. PMID 8942202 DOI: 10.1016/S0033-3182(96)71515-3 |
0.553 |
|
| 1996 |
Tedlow JR, Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Rosenbaum JF. Are study dropouts different from completers? Biological Psychiatry. 40: 668-670. PMID 8886303 DOI: 10.1016/0006-3223(96)00204-1 |
0.529 |
|
| 1996 |
Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF. Patterns of personality disorder comorbidity in early-onset versus late- onset major depression American Journal of Psychiatry. 153: 1308-1312. PMID 8831439 DOI: 10.1176/Ajp.153.10.1308 |
0.651 |
|
| 1996 |
Demopulos C, Fava M, Mclean NE, Alpert JE, Nierenberg AA, Rosenbaum JF. Hypochondriacal concerns in depressed outpatients Psychosomatic Medicine. 58: 314-320. PMID 8827793 DOI: 10.1097/00006842-199607000-00003 |
0.671 |
|
| 1996 |
Alpert JE, Maddocks A, Nierenberg AA, O'Sullivan R, Pava JA, Worthington JJ, Biederman J, Rosenbaum JF, Fava M. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Research. 62: 213-9. PMID 8804131 DOI: 10.1016/0165-1781(96)02912-5 |
0.586 |
|
| 1996 |
Fava M, Abraham M, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF. Gender differences in Axis I comorbidity among depressed outpatients. Journal of Affective Disorders. 38: 129-33. PMID 8791181 DOI: 10.1016/0165-0327(96)00004-3 |
0.644 |
|
| 1996 |
Fava M, Alpert J, Nierenberg AA, Ghaemi N, O'Sullivan R, Tedlow J, Worthington J, Rosenbaum JF. Fluoxetine treatment of anger attacks: a replication study. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 8: 7-10. PMID 8743642 DOI: 10.3109/10401239609149084 |
0.551 |
|
| 1995 |
Fava M, Rappe SM, Pava JA, Nierenberg AA, Alpert JE, Rosenbaum JF. Relapse in patients on long-term fluoxetine treatment: Response to increased fluoxetine dose Journal of Clinical Psychiatry. 56: 52-55. PMID 7852252 |
0.318 |
|
| 1995 |
Alpert JE, Uebelacker LA, McLean NE, Abraham M, Rosenbaum JF, Fava M. The Mini-Mental State Examination among adult outpatients with major depressive disorder Psychotherapy and Psychosomatics. 63: 207-211. PMID 7624468 DOI: 10.1159/000288961 |
0.652 |
|
| 1995 |
Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. The American Journal of Psychiatry. 152: 1500-3. PMID 7573590 DOI: 10.1176/Ajp.152.10.1500 |
0.448 |
|
| 1995 |
Baldessarini RJ, Nordby G, Ekeberg Ø, Knardahl S, Os I, Bleeker JK, Lamers LM, Leenders IM, Kruyssen DC, Simoons ML, Trijsburg RW, Erdman RA, Fukunishi I, Moroji T, Okabe S, ... ... Alpert JE, et al. Contents, Vol. 63, 1995 Psychotherapy and Psychosomatics. 63. DOI: 10.1159/000288982 |
0.344 |
|
| 1995 |
Nierenberg A, Phillips K, Uebelacker L, Alpert J, Worthington J, Fava M. Body dysmorphic disorder is comorbid with major depression Biological Psychiatry. 37: 611. DOI: 10.1016/0006-3223(95)94480-K |
0.631 |
|
| 1994 |
Alpert JE, Maddocks A, Rosenbaum JF, Fava M. Childhood psychopathology retrospectively assessed among adults with early onset major depression Journal of Affective Disorders. 31: 165-171. PMID 7963068 DOI: 10.1016/0165-0327(94)90025-6 |
0.663 |
|
| 1986 |
Elliott PJ, Alpert JE, Bannon MJ, Iversen SD. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Research. 363: 145-7. PMID 2418910 DOI: 10.1016/0006-8993(86)90667-0 |
0.564 |
|
| 1985 |
Tam FW, Chen C, Alpert JE, Iversen SD. Aversive effects of subcutaneously injected vasopressin in the rat: independence of the ascending dorsal noradrenergic bundle. Brain Research. 337: 133-7. PMID 3924347 DOI: 10.1016/0006-8993(85)91617-8 |
0.352 |
|
| 1984 |
Salamone JD, Beart PM, Alpert JE, Iversen SD. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Behavioural Brain Research. 13: 63-70. PMID 6541050 DOI: 10.1016/0166-4328(84)90030-5 |
0.524 |
|
| 1984 |
Dunn AJ, Alpert JE, Iversen SD. Dopamine denervation of frontal cortex or nucleus accumbens does not affect ACTH-induced grooming behaviour. Behavioural Brain Research. 12: 307-15. PMID 6087843 DOI: 10.1016/0166-4328(84)90156-6 |
0.36 |
|
| 1983 |
Hagan JJ, Alpert JE, Morris RG, Iversen SD. The effects of central catecholamine depletions on spatial learning in rats. Behavioural Brain Research. 9: 83-104. PMID 6882520 DOI: 10.1016/0166-4328(83)90015-3 |
0.334 |
|
| 1983 |
Alpert JE, Iversen SD. Striatal and limbic dopamine function: evidence from animal studies. Annals of Neurology. 13: 578. PMID 6683480 DOI: 10.1002/ana.410130518 |
0.341 |
|
| 1983 |
Schneider LH, Alpert JE, Iversen SD. CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors. Peptides. 4: 749-53. PMID 6318205 DOI: 10.1016/0196-9781(83)90031-1 |
0.356 |
|
| 1983 |
Bannon MJ, Elliott PJ, Alpert JE, Goedert M, Iversen SD, Iversen LL. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature. 306: 791-2. PMID 6197656 DOI: 10.1038/306791A0 |
0.562 |
|
| 1982 |
Iversen SD, Alpert JE. Functional organization of the dopamine system in normal and abnormal behavior. Advances in Neurology. 35: 69-76. PMID 6959523 |
0.336 |
|
| 1980 |
Piccirillo M, Alpert JE, Cohen DJ, Shaywitz BA. Effects of 6-hydroxydopamine and amphetamine on rat mothering behavior and offspring development. Pharmacology, Biochemistry, and Behavior. 13: 391-5. PMID 7422694 DOI: 10.1016/0091-3057(80)90244-0 |
0.365 |
|
| 1980 |
Piccirillo M, Alpert JE, Cohen DJ, Shaywitz BA. Amphetamine and maternal behavior: dose response relationships. Psychopharmacology. 70: 195-9. PMID 6776580 DOI: 10.1007/Bf00435314 |
0.357 |
|
| 1979 |
Piccirillo M, Cohen DJ, Shaywitz BA, Alpert JE, Marinelli D. Maternal care received by rat pups treated with 6-hydroxydopamine. Physiology & Behavior. 22: 69-75. PMID 572074 DOI: 10.1016/0031-9384(79)90406-2 |
0.365 |
|
| 1978 |
Alpert JE, Cohen DJ, Shaywitz BA, Piccirillo M, Shaywitz SE. Animal models and childhood behavioral disturbances: dopamine depletion in the newborn rat pup. Journal of the American Academy of Child Psychiatry. 17: 239-51. PMID 659743 DOI: 10.1016/S0002-7138(10)60089-1 |
0.366 |
|
| Show low-probability matches. |
